Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients
Status:
Not yet recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
A double-blind, multi-centre, randomized, placebo-controlled, feasibility pilot trial in the
prevention of new onset atrial fibrillation of critically ill patients admitted to an ICU.
Phase:
Phase 4
Details
Lead Sponsor:
Queen's University
Collaborator:
Southeastern Ontario Academic Medical Organization (SEAMO)